1. 2SPD-001 Use and cost evolution of infliximab and adalimumab over 8 years in a tertiary hospital. Issue 1 (23rd March 2023) Authors: Gómez, A; Carrillo López, V; Lopez, M; Royo, V; Santandreu, MM; Pérez, MF; Khorrami, S; Iglesias, MC; Delgado, O; Ginard, D Journal: European journal of hospital pharmacy Issue: Volume 30:Issue 1(2023)supplement 1 Page Start: A6 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗